Loading…
This event has ended. Visit the official site or create your own event on Sched.
Credit Type: RN [clear filter]
arrow_back View All Dates
Tuesday, June 28
 

8:00am EDT

10:30am EDT

#207: Advancing the Appropriate Use of Mobile Clinical Trials: The Clinical Trials Transformation Initiative 108A #213: FDA Enforcement Update: Advertising and Promotion 107AB #215: Exploring the Use of Virtual Technologies and Virtual Teams Within Medical Affairs Organizations 202AB #218: Lessons Learned from Eight Years of Drug Development Tool/Novel Methodology Qualification 201B #220: Regulatory Changes in China and the Impact to Global Drug Development Planning 109AB #222: Valuing the Clinical Trial Patient 204A #224: Identifying Patient-Centered Outcomes for Use in Observational Research: Why and How 201A #227: Unique Global Regulatory Considerations and Drug Development Incentives in Rare Disease and Orphan Drug Development 103C #208: Measuring Return on Engagement: An Interim Report on the DIA-Tufts CSDD Metrics Study 108B #209: The Promotable Project Manager: Leadership Behaviors Critical to Success in the Life Sciences 102AB #210: Effective Strategies to Leverage PMO Best Practices for Program and Portfolio Management 105AB #211: Collaboration with a Purpose 111AB #212: Special Populations in Clinical Pharmacology Studies 113A #214: Product Management Strategies: Maximizing Content Re-Use to Meet Diverse Customer Information Needs 203AB #217: Electronic Submissions Gateway: Next Generation 201C #216: Implementing a Successful Metadata Repository: The Journey of a Thousand Milestones Begins with a Single Step 204C #219: Regulatory Science Considerations Applying to Novel Combinations of Biologics and Bifunctional Biologics Development 204B #221: Envision the Future: How Big Data and Artificial Intelligence Change Our Regulatory Environment 103A #223: Global Harmonization: Current ICH Quality Initiatives 112AB #226: The Global Conundrum: Herding Cats - Identifying Risk Across Pharmacovigilance Networks and Seeking Simplicity in Multi-Country Pharmacovigilance Activities 113C #225: One Size Does Not Fit All: Best Practices for Right-Sized Signal Management Systems 113B

2:00pm EDT

#235: Global Clinical Supply Logistics Study 113A #237: Acquisitions and Mergers: When Companies’ Regulatory Operations Systems and Processes Converge 112AB #252: Capturing Real-World Data in Rare Diseases 103C #253: Update from Health Canada 202AB #234: TransCelerate's Risk-Based Monitoring: Sharing What We Are Learning 109AB #236: Expanded Access: Ethical, Regulatory, and Policy Challenges and Considerations 108B #238: Prescription Drug Marketing Regulatory Primer 107AB #240: CFAST at Year Three: Innovative Approaches to Adding Breadth, Depth, and Value to Therapeutic Area Standards 204B #239: Cloud Compliance: Clinical Software Challenges and Vendor Auditor Views 201C #241: Disease Interception: Shifting the Paradigm from Treatment to Prevention of Disease 201B #242: Regulatory Challenges in the Development of Combination Products Involving Digital Technology 108A #243: Patient Involvement Today and Tomorrow: What’s in It for Patients? 204C #244: Transforming Clinical Development Through Enterprise Quality Management 204A #245: Risk-Based Inspections 111AB #246: Valuing the Signal and the Noise in Health Care Horizon Scanning 103A #247: Fit for Purpose and Modern Validity Theory in PROs 105AB #248: Mind the Gaps: The Science of Designing, Implementing, and Evaluating Benefit-Risk Communication for Medicinal Products 113C #249: Current Topics for Pharmacovigilance in Japan 113B #250: Open-Label, Long-Term Extension Studies: Study Designs and Ethics 201A #251: Embracing Virtual Training Solutions in 2016: Focus on Performance! 102AB #254: CBER Town Hall: State of the Center and Plans for the Future 203AB

4:00pm EDT

 

Filter sessions
Apply filters to sessions.
Filtered by Credit Type (RN) - 
  • Preconference Tutorial
  • Trk 01: Clinical Operations
  • Trk 02: Proj-Port Mgt-Strat Planning
  • Trk 02: Proj/Port Mgt/Strat Planning
  • Trk 03: Innov Part Model-Outsourcing
  • Trk 03: Innov Part Model/Outsourcing
  • Trk 04: Preclin Transl-Early Clin Dev
  • Trk 05: Reg of Prod Adv-Mkting
  • Trk 05: Reg of Prod Adv/Mkting
  • Trk 06: Med Comm-Wrtg-MSL
  • Trk 06: Med Comm/Wrtg/MSL
  • Trk 07: Tech-Data- Records-Subs
  • Trk 07: Tech/Data/ Records/Subs
  • Trk 08: Reg Affairs
  • Trk 09: Med Devices-InVitro-CombProd
  • Trk 09: Med Devices/InVitro/CombProd
  • Trk 10: Pub Pol-HealthCare Compl-Law
  • Trk 10: Pub Pol/HealthCare Compl/Law
  • Trk 11: Quality in CT-GCP
  • Trk 11: Quality in CT/GCP
  • Trk 12: Pharm Quality
  • Trk 13: CER-Glob Health Econ
  • Trk 13: CER/Glob Health Econ
  • Trk 14: Clin Safety-PV
  • Trk 14: Clin Safety/PV
  • Trk 15: Statistics
  • Trk 16: Prof Development
  • Trk 17: Rare-Orphan Diseases
  • Trk 17: Rare/Orphan Diseases
  • Trk 18: Global Regulatory
  • Trk 19: DIAmond
  • Trk 20: Innov Theater
  • Trk 21: Poster Presentations
  • Trk 22: Engage and Exchange
  • Trk 23: Opening Plenary
  • Credit Type
  • ACPE
  • CME
  • IACET
  • PMI
  • RN
  • Audience
  • Advanced
  • Basic
  • Intermediate
  • Featured Topics
  • 21st Century Cures
  • Agency Participation
  • Approval Pathways
  • Audits and Inspections
  • Benefit-Risk
  • Big Data
  • Biologics-Biosimilars
  • Clinical Trial Designs
  • Clinical Trial Transparency-Clinical Trial Disclos
  • Cloud Computing
  • Community-led-Scientific Working Group Offerings
  • Current Issues in Policy and Law
  • Design Thinking
  • Disease Specific
  • Disruptive Technologies
  • Electronic Health Records (EHR)
  • Emerging Markets
  • GDUFA-Generics
  • Hot Topics in Policy and Law
  • IDMP
  • Increasing Research and Development Innovation
  • Interactive Workshop
  • Labeling
  • Mobile-Wearable Technology
  • Observational Studies
  • Partnership Strategies
  • Patient Engagement
  • Patient Recruitment and Retention
  • Patient Registries
  • Pediatrics
  • Precision-Personalized Medicine-Targeted Therapy
  • Pricing- Reimbursement and Access
  • Program Offerings for Student Attendees
  • R&D Innovation
  • Regulatory Harmonization-Convergence
  • Risk Evaluation and Mitigation Strategies (REMS)
  • Risk-Based Monitoring
  • Social Media Strategies
  • Topics Related to Asia-Pacific Region
  • Topics Related to Canada
  • Topics Related to China
  • Topics Related to Europe-EMEA
  • Topics Related to India
  • Topics Related to Japan
  • Vaccines
  • Value-Based Evidence
  • Women's Health
  • Interest Area
  • Academic Health Centers-Investigative Sites
  • Advertising & Promotion
  • Biotechnology
  • Clinical Data Management
  • Clinical Data Management - eClinical
  • Clinical Research
  • Clinical Safety & Pharmacovigilance
  • Clinical Supplies
  • CMC
  • CMC-GMP
  • Combination Products
  • Comparative Effectiveness
  • Document & Records Management
  • eClinical
  • Finance
  • Good Clinical Practices & QA
  • Information Technology
  • Manufacturing
  • Marketing & Sales
  • Medical Communications
  • Medical Devices & Diagnostics
  • Medical Science Liaison
  • Medical Writing
  • Non-clinical Safety
  • Outsourcing
  • Patient Engagement
  • Pharmaceutics
  • Pricing - Reimbursement
  • Professional Education - Training & Development
  • Project Management
  • Public Policy - Health Care Compliance - Law
  • Public Policy - Law
  • QA-QC
  • Quality Assurance - Quality Control
  • R&D - Strategic Issues
  • Rare - Orphan Diseases
  • Regulatory Affairs
  • Statistics
  • Strategic Planning
  • Study Endpoints
  • Submissions
  • Val - Electronic Info Integrity